Facebook
Twitter
LinkedIn
Forward
2022 San Antonio Breast Cancer Symposium Review
This conference will review and discuss the high-impact findings, with clinical relevance for physicians caring for women with breast cancer, that are presented each year at the International San Antonio Breast Cancer Symposium. Practicing clinicians and other oncology health care professionals who are unable to attend the meeting in San Antonio will benefit from a presentation of the symposium highlights, which will offer an opportunity for interactive discussion with expert faculty.
This course will be conducted in a hybrid format; in-person event, but also offering virtual attendance. A link to the livestream will be sent to virtual registrants the week of the conference.
Please contact Bernice Sulkowski with any questions.
Pricing:
| In-Person Attendee - Physicians, $50.00 |
| In-Person Attendee - Other Healthcare Professionals, $30.00 |
| In-Person Attendee - Fellows and Residents, $0.00 |
| In-Person Attendee - Patient Advocates, $0.00 |
| Virtual Attendee, $30.00 |
Target Audience
This conference has been designed to provide practicing oncologists, surgeons, radiologists, and other health care professionals information on current concepts in the management of patients with breast cancer.
Additional Information
| Attachment | Size |
|---|---|
 SanAntonio Breast Review Brochure.pdf | 692.37 KB |
8am – 9am - Registration, Breakfast, Visit Vendors
9am – 9:05am – Welcome
SYSTEMIC BREAST CANCER MANAGEMENT
9:05am – 9:35am - HER2 Positive Breast Cancer Update - Dr. Christie Hilton
9:35am – 9:55am - HER2 low: a pathologist's perspective - Dr. Alex Bousamra
9:55am – 10:25am - Hormone Positive Breast Cancer Update - Dr. Casey Moffa
10:25am – 10:55am - High Risk Hormone Positive Cancer Update - Dr. Diane Buchbarker
10:55am – 11:10am - Break/Visit Vendors
11:10am – 11:40am - SERDS Treatment-The New Frontier - Dr. Helen Analo
11:40am – 11:55am - TROPiCS-02 Study - Dr. Saleha Rizwan
11:55am – 12:10pm - Pregnancy and Breast Cancer: The Positive Study - Dr. Gurleen Pasricha
12:10pm – 12:25pm - Low Dose Tamoxifen - Dr. Sarah Miller
12:25pm – 12:40pm Palbociclib After CDK4/6i and Endocrine Therapy: The PACE Study - Dr. Maitreyee Rai
12:40pm – 1:40pm - Lunch
LOCAL/REGIONAL BREAST CANCER TREATMENT
1:40pm – 1:55pm - Management of the Axilla - Dr. Jennifer Saldanha
1:55pm – 2:10pm - ACOSOG Z11102: Breast Conservation Therapy - Dr. Suzanne Coopey
2:10pm – 2:25pm - The Omission of Axillary Lymph Node Dissection after NCT pCR - Dr.Emil Fernando
2:25pm – 2:40pm - Contralateral Breast Cancer Risk with Carriers of Pathogenic Variants - Dr. Janette Gomez
2:40pm – 2:55pm - Break/Visit Vendors
2:55pm – 3:10pm - Hypofractionated Radiotherapy in patients with Breast Cancer - Dr. Bindu Rusia
3:10pm – 3:25pm - Omission of Local Adjuvant Radiotherapy: The POLAR Study - Dr. Colin Champ
3:25pm – 3:45pm - The Role of Advanced Radiation Technology in Reducing Toxicity - Dr. Mark Trombetta
3:45 – Adjournment
Lodging
A reduced rate of $239 at the Fairmont Pittsburgh is available until January 10, 2023 or until the block is full – whichever comes first.
Call 412-773-8800 to make a reservation. Reference "AHN Breast Cancer Symposium". Parking will be validated.
Physicians Allegheny General Hospital is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Approved for 5.50 AMA PRA Category 1 Credit™.
American Nurses Credentialing Center (ANCC) accepts AMA PRA Category 1 Credits™ from organizations accredited by the ACCME.
American Academy of Nurse Practitioners (AANP) accepts AMA PRA Category 1 Credits™ from organizations accredited by the ACCME.
The National Commission on Certification of Physician Assistants (NCCPA) states that the AMA PRA Category 1 Credits™ are acceptable for continuing medical education requirements for recertification.
Allegheny General Hospital has approved this activity for contact hours for non-physicians.
Available Credit
- 5.50 AMA PRA Category 1 Credit™
- 5.50 Attendance